SM Empreendimentos-Purifarma deal should be blocked, says Brazil CADE Superintendence
The investigative body of the Brazilian competition watchdog has recommended blocking a deal involving SM Empreendimentos and Purifarma in the pharmaceutical industry. The unit concluded that competition would be harmed in...To view the full article, register now.
Already a subscriber? Click here to view full article